Inhibrx, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 0.119 million compared to USD 0.278 million a year ago. Net loss was USD 51.79 million compared to USD 35.33 million a year ago. Basic loss per share from continuing operations was USD 1.1 compared to USD 0.9 a year ago.
For the nine months, revenue was USD 0.166 million compared to USD 1.92 million a year ago. Net loss was USD 147.76 million compared to USD 104.31 million a year ago. Basic loss per share from continuing operations was USD 3.3 compared to USD 2.67 a year ago.